The appointment of "yet" another director could also imply that they're preparing to ramp up for upcoming events. But your guess is as good as mine. Bad or good, I haven't decided yet.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game